You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Liver disease has been identified as a leading cause of death in HIV-infected patients since the introduction of highly active antiretroviral therapy (HAART) in 1996. The HIV treatment community has been caught largely unaware of this emerging dilemma. Many HIV care providers are ill-equipped to understand and interpret liver injury patterns, or to provide comprehensive care and management for viral coinfections which they are not familiar with. HIV and Liver Disease provides a comprehensive update of the field covering the epidemiology, pathogenesis, management and treatment of liver disease in patients with HIV infection. The volume will help HIV care providers understand and interpret liv...
(Peeters 1992)
Viral Insecticides for Biological Control focuses on the basic as well as applied aspects of viral insecticides, which have the potential to significantly reduce the current reliance on chemical pesticide technology. This book serves as a guide for the development of means to identify hazardous problems and prevent them. Organized into six parts with a total of 23 chapters, this book describes the taxonomy, nomenclature, identification, physical, biological, as well as chemical characteristics, replication, and pathology of insect viruses. This reference material also explores the dispersal, stability, and utilization of insect viruses as biological control agents. The factors and considerations that must be taken into account when a viral insecticide is sought as a large-scale commercial alternative to other more traditional methods of pest control are also addressed. Because this reference material collates information in this field of interest, it will benefit a wide audience of readers, including researchers, students, and those working directly in crop protection.
This up-to-date reference serves as a comprehensive overview of, and patient treatment manual for, chronic viral hepatitis-accounting for subtleties in the diagnosis and treatment of individual patients, rapidly evolving concepts in patient management, and heightened public awareness of the disease. Illustrates how current advances in diagnostic and therapeutic modalities may benefit patients with chronic viral hepatitis! Organized in an easily consulted case-study format that focuses on relevant and challenging patient cases in each chapter, Management of Chronic Viral Hepatitis reviews the transition from biochemical measurements to therapy based on viral endpoints and direct antivirals de...
In a detailed engagement with the psychoanalytic theories of dreams, conscience, empathy, and creativity, Dan Merkur argues that the superego is an unconscious reasoning process, dedicated to the representation of the loved object. The superego's access to the repressed and devotion of time to single topics make it both more knowledgeable and more intelligent than the conscious ego. This is the final installment in Merkur's three-volume exploration of the psychoanalysis of religious experiences—volumes one and two are The Ecstatic Imagination: Psychedelic Experiences and the Psychoanalysis of Self-Actualization and Mystical Moments and Unitive Thinking, also published by SUNY Press.
Cincinnati Magazine taps into the DNA of the city, exploring shopping, dining, living, and culture and giving readers a ringside seat on the issues shaping the region.
There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.This number is only expected to grow a...